These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29680103)

  • 1. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.
    Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
    Value Health; 2018 Apr; 21(4):456-461. PubMed ID: 29680103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.
    Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
    Value Health; 2019 Jan; 22(1):38-44. PubMed ID: 30661632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a Smaller Design for EQ-5D-5L Valuation Studies.
    Yang Z; Luo N; Oppe M; Bonsel G; Busschbach J; Stolk E
    Value Health; 2019 Nov; 22(11):1295-1302. PubMed ID: 31708067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.
    Jyani G; Yang Z; Sharma A; Goyal A; Stolk E; Purba FD; Grover S; Kaur M; Prinja S
    Med Decis Making; 2023 Aug; 43(6):692-703. PubMed ID: 37480281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach.
    Pullenayegum EM; Chan KK; Xie F
    Med Decis Making; 2016 Feb; 36(2):223-33. PubMed ID: 26139449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese time trade-off values for EQ-5D health states.
    Liu GG; Wu H; Li M; Gao C; Luo N
    Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK; Tabberer M; Brooks J
    Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms.
    Woodcock F; Doble B;
    Med Decis Making; 2018 Nov; 38(8):954-967. PubMed ID: 30226101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Experience-Based Value Set for the EQ-5D-5L in Germany.
    Leidl R; Reitmeir P
    Value Health; 2017 Sep; 20(8):1150-1156. PubMed ID: 28964448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.
    Rand-Hendriksen K; Ramos-Goñi JM; Augestad LA; Luo N
    Value Health; 2017; 20(7):945-952. PubMed ID: 28712624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.
    Kharroubi SA; Beyh YS; Brazier J; Yang Y
    Qual Life Res; 2020 Jun; 29(6):1495-1507. PubMed ID: 32016681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuation of Quality Weights for EuroQol 5-Dimensional Health States With the Time Trade-Off Method in the Capital of Iran.
    Goudarzi R; Sari AA; Zeraati H; Rashidian A; Mohammad K; Amini S
    Value Health Reg Issues; 2019 May; 18():170-175. PubMed ID: 31096140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
    Couzner L; Crotty M; Norman R; Ratcliffe J
    Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.
    Golicki D; Niewada M; Hout BV; Janssen MF; Pickard AS
    Value Health Reg Issues; 2014 Sep; 4():19-23. PubMed ID: 29702801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.
    Selivanova A; Buskens E; Krabbe PFM
    Pharmacoeconomics; 2018 Jun; 36(6):715-725. PubMed ID: 29623559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
    Hernández Alava M; Wailoo AJ; Ara R
    Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets.
    Kularatna S; Chen G; Byrnes J; Scuffham PA
    Value Health Reg Issues; 2017 May; 12():20-23. PubMed ID: 28648311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence.
    Yang Z; Feng Z; Busschbach J; Stolk E; Luo N
    Value Health; 2019 Jul; 22(7):829-836. PubMed ID: 31277831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.